Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response


Journal article


Zhisheng Her, Zhisheng Her, Terk-Shin Teng, Jeslin J L Tan, Teck-Hui Teo, Teck-Hui Teo, Yiu-Wing Kam, Fok-Moon Lum, Fok-Moon Lum, Wendy W L Lee, Wendy W L Lee, Christelle Gabriel, Rossella Melchiotti, Rossella Melchiotti, Anand K Andiappan, Valeria Lulla, Aleksei Lulla, Mar K Win, Angela Chow, Subhra K Biswas, Yee-Sin Leo, Marc Lecuit, Andres Merits, Laurent Rénia, Lisa F P Ng, Lisa F P Ng, Lisa F P Ng
Embo Molecular Medicine, vol. 7(1), 2015 1, pp. 24-41

Cite

Cite

APA
Her, Z., Her, Z., Teng, T.-S., Tan, J. J. L., Teo, T.-H., Teo, T.-H., … Ng, L. F. P. (2015). Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response. Embo Molecular Medicine, 7(1), 24–41.

Chicago/Turabian
Her, Zhisheng, Zhisheng Her, Terk-Shin Teng, Jeslin J L Tan, Teck-Hui Teo, Teck-Hui Teo, Yiu-Wing Kam, et al. “Loss of TLR3 Aggravates CHIKV Replication and Pathology Due to an Altered Virus‐Specific Neutralizing Antibody Response.” Embo Molecular Medicine 7, no. 1 (December 1, 2015): 24–41.

MLA
Her, Zhisheng, et al. “Loss of TLR3 Aggravates CHIKV Replication and Pathology Due to an Altered Virus‐Specific Neutralizing Antibody Response.” Embo Molecular Medicine, vol. 7, no. 1, Dec. 2015, pp. 24–41.